SIRT4 Alleviates Retinal Ischemia-Reperfusion Injury Via Mediating Astrocytes Lipid Metabolism and Mitochondrial Function
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.6.49 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2026. Verfasst von Hongdou Luo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Eye Hospital of Nanchang University, Jiangxi Research Institute of Ophthalmology and Visual Science, Jiangxi Provincial Key Laboratory for…. Hauptthemen laut MEDLINE: Reperfusion Injury, Astrocytes, Mitochondria, Sirtuins. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Purpose
To investigate whether SIRT4 protects the optic nerve by regulating mitochondrial function and lipid metabolism in neurotoxic reactive astrocytes in the retinal ischemia-reperfusion injury.
Methods
Using SIRT4 knockout, wild-type, and overexpressing mouse ischemia-reperfusion (I/R) models, we assessed retinal ganglion cell loss, protein expression (SIRT4, APOL6, GBP2, mitochondrial dynamics), and conducted metabolomic/transcriptomic analyses. In vitro, primary astrocytes were treated with TIC cytokines; SIRT4 was knocked down via lentivirus, followed by measurement of ATP, lipid secretion, and mitochondrial morphology/function.
Results
SIRT4 was highly expressed in astrocytes. Its knockdown exacerbated I/R injury, promoting a neurotoxic astrocyte phenotype with increased APOL6 expression, and elevated secretion of long-chain fatty acids and phosphatidylcholines and mitochondrial damage. SIRT4 deficiency enhanced astrocyte susceptibility to injury, further reducing ATP production and worsening lipid accumulation and optic nerve damage.
Conclusions
SIRT4 plays a protective role in retinal ischemia-reperfusion injury model by regulating astrocyte lipid metabolism and mitochondrial function, offering a potential therapeutic target for neuroprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Affiliated Eye Hospital of Nanchang University, Jiangxi Research Institute of Ophthalmology and Visual Science, Jiangxi Provincial Key Laboratory for Ophthalmology, Jiangxi Clinical Research Center for Ophthalmic Diseas…
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
- State Key Laboratory of Ophthalmology, Optometry and Visual Science, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
- The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Zitieren
APA
Luo, H., Jin, M., Xu, K., Zheng, H., Zhang, W., Gu, X., Deng, C., Chen, Z., Xiong, C., & Zhang, X. (2026). SIRT4 Alleviates Retinal Ischemia-Reperfusion Injury Via Mediating Astrocytes Lipid Metabolism and Mitochondrial Function. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.6.49
Vancouver
Luo H, Jin M, Xu K, Zheng H, Zhang W, Gu X, et al. SIRT4 Alleviates Retinal Ischemia-Reperfusion Injury Via Mediating Astrocytes Lipid Metabolism and Mitochondrial Function. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.6.49
BibTeX
@article{Luo2026,
author = {Luo, Hongdou and Jin, Ming and Xu, Ke and Zheng, Haina and Zhang, Wenyige and Gu, Xuejun and Deng, Cong and Chen, Zhuo and Xiong, Chan and Zhang, Xu},
title = {SIRT4 Alleviates Retinal Ischemia-Reperfusion Injury Via Mediating Astrocytes Lipid Metabolism and Mitochondrial Function},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.6.49}
}
EUVIMED